Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits
Ageing Research Reviews · 2024-09 · 100 · 102386
DOI: 10.1016/j.arr.2024.102386 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2024-09. Verfasst von Saurabh Kumar Jha und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Kalindi College, University of Delhi, 110008, India. Electronic address: Jhasaurabh017@gmail.com. Hauptthemen laut MEDLINE: Cannabidiol, Neurodegenerative Diseases. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 163 Literaturangaben. Gefördert von: Northern Borders University.
Abstract (Originalsprache)
Neurodegenerative disorders (NDs) such as Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, and amyotrophic lateral sclerosis are severe and life-threatening conditions in which significant damage of functional neurons occurs to produce psycho-motor malfunctions. NDs are an important cause of death in the elderly population worldwide. These disorders are commonly associated with the progression of age, oxidative stress, and environmental pollutants, which are the major etiological factors. Abnormal aggregation of specific proteins such as α-synuclein, amyloid-β, huntingtin, and tau, and accumulation of the associated oligomers in neurons are the hallmark pathological features of NDs. Existing therapeutic options for NDs are only symptomatic relief and do not address root-causing factors, such as protein aggregation, oxidative stress, and neuroinflammation. Cannabidiol (CBD) is a non-psychotic natural cannabinoid obtained from Cannabis sativa that possesses multiple pharmacological actions, including antioxidant, anti-inflammatory, and neuroprotective effects in various NDs and other neurological disorders both in vitro and in vivo. CBD has gained attention as a promising drug candidate for the management of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, by inhibiting protein aggregation, free radicals, and neuroinflammation. In parallel, CBD has shown positive results in other neurological disorders, such as epilepsy, depression, schizophrenia, and anxiety, as well as adjuvant treatment with existing standard therapeutic agents. Hence, the present review focuses on exploring the possible molecular mechanisms in controlling various neurological disorders as well as the clinical applications of CBD in NDs including epilepsy, depression and anxiety. In this way, the current review will serve as a standalone reference for the researchers working in this area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Zoology, Kalindi College, University of Delhi, 110008, India. Electronic address: Jhasaurabh017@gmail.com.
- Center for Global Health Research, Saveetha Medical College, Saveetha Institute Of Medical And Technical Sciences, India.
- Faculty of Pharmacy, Lincoln University College, Malaysia.
- Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh 281406, India.
- Department of Chemistry, Siddha Central Research Institute, Central Council for Research in Siddha, Ministry of AYUSH, Govt. of India, Chennai, Tamil Nadu, India.
- Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India.
Förderung
- Northern Borders University
Zitieren
APA
Jha, S. K., Nelson, V. K., Suryadevara, P. R., Panda, S. P., Pullaiah, C. P., Nuli, M. V., Kamal, M., Imran, M., Ausali, S., Abomughaid, M. M., Srivastava, R., Deka, R., Pritam, P., Gupta, N., Shyam, H., Singh, I. K., Pandey, B. W., Dewanjee, S., Jha, N. K., & Jafari, S. M. (2024). Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits. Ageing Research Reviews, 100, 102386. https://doi.org/10.1016/j.arr.2024.102386
Vancouver
Jha SK, Nelson VK, Suryadevara PR, Panda SP, Pullaiah CP, Nuli MV, et al. Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits. Ageing Research Reviews. 2024;100:102386. doi:10.1016/j.arr.2024.102386
BibTeX
@article{Jha2024,
author = {Jha, Saurabh Kumar and Nelson, Vinod Kumar and Suryadevara, Punna Rao and Panda, Siva Prasad and Pullaiah, Chitikela P and Nuli, Mohana Vamsi and Kamal, Mehnaz and Imran, Mohd and Ausali, Saijyothi and Abomughaid, Mosleh Mohammad and Srivastava, Rashi and Deka, Rahul and Pritam, Pingal and Gupta, Neha and Shyam, Harishankar and Singh, Indrakant K and Pandey, Bindhy Wasini and Dewanjee, Saikat and Jha, Niraj Kumar and Jafari, Seid Mahdi},
title = {Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits},
journal = {Ageing Research Reviews},
year = {2024},
volume = {100},
pages = {102386},
doi = {10.1016/j.arr.2024.102386}
}
EUVIMED